AMICUS: AN EPIDEMIC OF GOODWILL
Amicus is a grassroots movement which has grown up in support of taking an innovative HIV&AIDS immunotherapy through clinical trials.
It has become an epidemic - an epidemic of goodwill. In little over a month, people now in 22 countries and 5 out of the 7 continents have joined up over facebook in support of an innovative immunotherapy in the treatment of HIV&AIDS.
Success in these trials could even mean a delay in the need for anti-retrovirals.
Only through the trials will the scientists know for sure. And as this is about a therapy and not a product, drug companies are not interested from a commercial perspective. That means there is no corporate investment behind it. The scientists need your help.
Visit www.amicus.net to learn about this important research and ways you can become part of our epidemic of goodwill.
Human Futures Foundation is a publically registered charity in the USA, Great Britain and Switzerland. Amicus is our public outreach program.
The Human Futures flagship program, the Global Consortium for Immunotherapy, in collaboration with the Human Biology Research Center at Hadassah University Hospital, seeks to assist in the development of an innovative, immunotherapeutic approach in the treatment of HIV infected individuals.